Barriers to antiretroviral adherence: The importance of depression, abuse, and other traumatic events

AIDS Patient Care and STDs

Volumn 20, Issue 6, 2006, Pages 418-428

  Mugavero, Michael ^a,b   Ostermann, Jan ^a,b   Whetten, Kathryn ^a,b   Leserman, Jane ^c   Swartz, Marvin ^a   Stangl, Dalene ^b   Thielman, Nathan ^a,b,d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ABUSE; ADULT; AGED; ALCOHOLISM; ARTICLE; COPING BEHAVIOR; DEPRESSION; DRUG ABUSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJURY; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; SELF REPORT; SEXUAL ABUSE; UNITED STATES; VIRUS RESISTANCE;

ADULT; AGED; ANTIVIRAL AGENTS; COUNSELING; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL TESTS; SEX OFFENSES; TREATMENT REFUSAL; WOUNDS AND INJURIES;

EID: 33745617444     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.418     Document Type: Article

References (57)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002;34:1115-1121.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
4. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 1999;13:1099-1107.
5. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-1183.
6. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr 2004;35:261-268.
7. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services (DHHS). October 29, 2004. www.aidsinfo.nih.gov/guidelines/adult/AA_102904.pdf
8. Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother 2004;53:696-699.
9. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003;37:1112-1118.
10. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med 2003;139:810-816.
11. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769.
12. Heckman BD, Catz SL, Heckman TG, Miller JG, Kalichman SC. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care 2004;16:219-230.
13. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 2004;18(Suppl 1):S19-25.
14. Mathews WC, Mar-Tang M, Ballard C, et al. Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patient Care STDs 2002;16:157-172.
15. Power R, Koopman C, Volk J, et al. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patient Care STDs 2003;17:245-252.
16. Singh IM, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-830.
17. Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDs 2002;16:599-608.
18. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-266.
19. Cohen MA, Alfonso CA, Hoffman RG, Milau V, Carrera G. The impact of PTSD on treatment adherence in persons with HIV infection. Gen Hosp Psychiatry 2001;23:294-296.
20. Ricart P, Cohen MA, Alfonso CA, et al. Understanding the psychodynamics of non-adherence to medical treatment in persons with HIV infection. Gen Hosp Psychiatry 2002;24:176-180.
21. Katz S, Nevid JS. Risk factors associated with post-traumatic stress disorder symptomatology in HIV-infected women. AIDS Patient Care STDs 2005;19:110-120.
22. Nannis ED, Patterson TL, Semple SJ. Coping with HIV disease among seropositive women: Psychosocial correlates. Women Health 1997;25:1-22.
23. Rothenberg KH, Paskey SJ. The risk of domestic violence and women with HIV infection: implications for partner notification, public policy, and the law. Am J Public Health 1995;85:1569-1576.
24. Cohen M, Deamant C, Barkan S, et al. Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV. Am J Public Health 2000;90:560-565.
25. Gielen AC, McDonnell KA, Wu AW, O'Campo P, Faden R. Quality of life among women living with HIV: The importance violence, social support, and self care behaviors. Soc Sd Med 2001;52:315-322.
26. Leserman J, Whetten K, Lowe K, Stangl D, Swartz MS, Thielman NM. How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. Psychosom Med 2005;67:500-507.
27. Wyatt GE, Myers HP, Williams JK, et al. Does a history of trauma contribute to HIV risk for women of color? Implications for prevention and policy. Am J Public Health 2002;2:660-665.
28. HIV/AIDS Surveillance Report 2002. Centers for Disease Control and Prevention, www.cdc.gov/hiv/stats/hasrlink.htm (Last accessed March 27, 2006).
29. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-441.
30. Godin G, Gagne C, Naccache H. Validation of a self-reported questionnaire assessing adherence to anti-retroviral medication. AIDS Patient Care STDs 2003;37:325-332.
31. Dubo SR, Felitti VJ, Dong M, Giles WH, Anda RF. The impact of adverse childhood experiences on health problems: Evidence from four birth cohorts dating back to 1900. Prev Med 2003;37:268-277.
32. Dube SR, Anda RP, Felitti VJ, Edwards VJ, Croft JB. Adverse childhood experiences and personal alcohol abuse as an adult. Addict Behav 2002;27:713-725.
33. Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RP. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: The adverse childhood experiences study. Pediatrics 2003;111:564-572.
34. Felitti VJ, Anda RP, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 1998;14:245-258.
35. Dong M, Giles WH, Felitti VJ, et al. Insights into causal pathways for ischemic heart disease: Adverse childhood experiences study. Circulation 2004;110:1761-1766.
36. Hillis SD, Anda RP, Felitti VJ, Marchbanks PA. Adverse childhood experiences and sexual risk behaviors in women: A retrospective cohort study. Fam Plann Perspect 2001;33:206-211.
37. Leserman J, Drossman DA, Li Z, Toomey TC, Nachman G, Glogau L. Sexual and physical abuse history in gastroenterology practice: How types of abuse impact health status. Psychosom Med 1996;58:4-15.
38. Leserman J, Li Z, Drossman DA, Toomey TC, Nachman G, Glogau L. Impact of sexual and physical abuse dimensions on health status: Development of an abuse severity measure. Psychosom Med 1997;59:152-160.
39. Badgley R, Allard, H, McCormick, N, Proudfood, P, Fortin, D, Ogilvie, D, Rae-Grant, Q, Gelinas, P, Pepin, L, Sutherland, S. Occurence in the Population. Ln: Anonymous Sexual Offences against Children, Vol. 1. Ottawa: Canadian Government Publishing Centre, 1984:175-193.
40. Koss MP, Gidycz CA. Sexual experiences survey: Reliability and validity. J Consult Clin Psychol 1985;53:422-423.
41. Kilpatrick D, Resnick HS. A description of the posttraumatic stress disorder field trial. In: Davidson J, Foa, EB, eds. Posttraumatic Stress Disorder: DSM-IV and Beyond. Washington, D.C.: American Psychiatric Press; 1993, pp. 113-143.
42. Leserman J, Li Z, Drossman DA, Hu YJ. Selected symptoms associated with sexual and physical abuse history among female patients with gastrointestinal disorders: The impact on subsequent health care visits. Psychol Med 1998;28:417-425.
43. Bernstein D, Pink, L. Childhood Trauma Questionnaire Manual. San Antonio, TX: The Psychological Corporation, 1998.
44. Carver C. You want to measure coping but your protocol's too long: Consider the Brief COPE. Int J Behav Med 1997;4:92-100.
45. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychol Med 1983;13:595-605.
46. McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199-213.
47. Bensley LS, Van Eenwyk J, Simmons KW. Self-reported childhood sexual and physical abuse and adult HIV-risk behaviors and heavy drinking. Am J Prev Med 2000;18:151-158.
48. McCauley J, Kern DE, Kolodner K, et al. Clinical characteristics of women with a history of childhood abuse: Unhealed wounds. JAMA 1997;277:1362-1368.
49. Molnar BE, Buka SL, Kessler RC. Child sexual abuse and subsequent psychopathology: Results from the National Comorbidity Survey. Am J Public Health 2001;91:753-760.
50. Parillo KM, Freeman RC, Collier K, Young P. Association between early sexual abuse and adult HIV-risky sexual behaviors among community-recruited women. Child Abuse Negl 2001;25:335-346.
51. Leserman J. The effects of depression, stressful life events, social support, and coping on the progression of HIV infection. Curr Psychiatry Rep 2000;2:495-502.
52. Leserman J, Petitto JM, Gu H, et al. Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychol Med 2002;32:1059-1073.
53. Cohen MH, Cook JA, Grey D, et al. Medically eligible women who do not use HAART: The importance of abuse, drug use, and race. Am J Public Health 2004;94:1147-1151.
54. Leenerts MH. The disconnected self: Consequences of abuse in a cohort of low-income white women living with HIV/AIDS. Health Care Women Int 1999;20:381-400.
55. McNutt LA, van Ryn M, Clark C, Fraiser I. Partner violence and medical encounters: African-American women's perspectives. Am J Prev Med 2000;19:264-269.
56. Wyatt GE, Longshore D, Chin D, et al. The efficacy of an integrated risk reduction intervention for HIV-positive women with child sexual abuse histories. AIDS Behav 2004;8:453-462.
57. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDs 2003;17:169-177.